Approximately 5% of patients with sarcoidosis will have clinically manifest cardiac
involvement presenting with one or more of ventricular arrhythmias, conduction …

Cardiac involvement is undeniably one of the most challenging issues in sarcoidosis.
Although autopsy studies reveal heart lesions in 20 to 30% of sarcoid patients, fewer than …

Sarcoidosis is a systemic disease with a favorable prognosis, high remission rate, and low
mortality. Cardiac involvement alters this prognosis. Clinical manifestations most commonly …

Clinical and subclinical cardiac sarcoidosis (CS) remains diagnostically challenging as the
sensitivity and specificity of the diagnostic modalities are limited. The Japanese Ministry of …

Clinically manifest cardiac involvement occurs in perhaps 5% of patients with sarcoidosis.
The 3 principal manifestations of cardiac sarcoidosis (CS) are conduction abnormalities …

Clinically evident sarcoidosis involving the heart has been noted in at least 2 to 7% of
patients with sarcoidosis, but occult involvement is much higher (> 20%). Cardiac …

Background Prognostic factors are lacking in cardiac sarcoidosis (CS), and the effects of
immunosuppressive treatments are unclear. Objectives To identify prognostic factors and to …

Increasing awareness of cardiac manifestations of sarcoidosis and the widespread
availability of advanced imaging tests have led to a tidal wave of interest in a condition that …

Background Cardiac sarcoidosis (CS) is a severe localization, observed mostly in cardiology
departments. Despite appropriate cardiological treatment, CS is a potentially life-threatening …

Studies have suggested that clinically manifest cardiac involvement occurs in perhaps 5% of
patients with pulmonary/systemic sarcoidosis. Clinical features of CS depend on the …